Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

webmd.com

1 of 0

Resource Description:

The FDA has approved the human papillomavirus (HPV) vaccine Cervarix for use in girls and young women ages 10-25 to help prevent cervical cancer.

« Back to the HPV Types 16 and 18 Vaccine Cervarix Gets FDA Approval for Use in Girls and Young Women WisdomCard

TrustedWisdom on

Expert review of this website

Related Health Centers:

Advertisement